NCT03314974 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders Status RECRUITING Phase PHASE2
NCT03297528 Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant Status UNKNOWN Phase PHASE2
NCT03279900 Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy Status COMPLETED Phase N/A
NCT03178617 High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT03176277 A Study of ONO-7475 in Patients With Acute Leukemias Status TERMINATED Phase PHASE1/PHASE2
NCT03138395 iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML Status WITHDRAWN Phase N/A
NCT03128359 High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT03096782 Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma Status COMPLETED Phase PHASE2
NCT02930109 A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT02877082 Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients Status TERMINATED Phase PHASE2
NCT02823132 Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia Status COMPLETED Phase N/A
NCT02822326 Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia Status UNKNOWN Phase PHASE1
NCT02752243 CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT. Status UNKNOWN Phase PHASE1/PHASE2